NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Nurix Therapeutics (NRIX): Assessing Valuation as Investors Await Key NX-5948 Clinical Data Webcast [Yahoo! Finance]
Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nurix Therapeutics (NASDAQ:NRIX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $30.00 price target on the stock.
Form 4 Nurix Therapeutics, Inc. For: Nov 24 Filed by: Ring Christine
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: Commodore Capital LP
Form 4 Nurix Therapeutics, Inc. For: Nov 06 Filed by: DANSEY ROGER D
Form 3 Nurix Therapeutics, Inc. For: Nov 06 Filed by: DANSEY ROGER D
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.